Aslan Fred

President and CEO, DirectorArtiva Biotherapeutics, Inc. (ARTV) · full profile →Form 4 · filed Aug 18, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$70K
Net Open-Market Flow
-$70K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 15, 2025Sell(S)26K$2.73$70K387K
Aug 15, 2025Tax withholding(F)4K$2.75$12K382K
May 15, 2025Tax withholding(F)4K$2.13$10K412K

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-022224) within minutes of acceptance. Every field above traces to the original document. Verify it directly: